Previous Close | 1.4600 |
Open | 1.5300 |
Bid | 1.4600 x 40000 |
Ask | 1.5400 x 40000 |
Day's Range | 1.4600 - 1.5300 |
52 Week Range | 0.4000 - 1.7600 |
Volume | |
Avg. Volume | 7,259 |
Market Cap | 108.284M |
Beta (5Y Monthly) | 1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | Oct 30, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Romeoville, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics — today announced the Company will disseminate a financial news release for the Third Quarter 2024 after market close on Wednesday, October 30, 2024, with an investor conference call t
Nanophase Technologies Corp (NANX) reports a 32% revenue increase in Q2 2024, with strategic plans to exceed $50 million in annual revenue and expand production capacity.